Concepedia

Keith J. Duff

KJ

9

Publications

461

Citations

9

H-Index

1989

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Restek (United States)

Pfizer (United States)

MatTek Corporation (United States)

University of Rhode Island

Keith J. Duff is an author at Bristol-Myers Squibb (United States) specializing in medicine, drug analysis, and chromatography.

Top concepts

Publications per year

1989–2000

9

Publications

9

The Use of Mesoporous Silica in Liquid Chromatography

Karl W. Gallis, James T. Araujo, Keith J. Duff et al. · Advanced Materials · 1999 · 178 citations

, , +13

Benzazepinone calcium channel blockers. 2. Structure activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones

David Floyd, S. David Kimball, John Krapcho et al. · Journal of Medicinal Chemistry · 1992 · 68 citations

Optimized stationary phases for the high-performance liquid chromatography–electrospray ionization mass spectrometric analysis of basic pharmaceuticals

Shane Needham, Phyllis R. Brown, Keith J. Duff et al. · Journal of Chromatography A · 2000 · 58 citations

, , +10

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site

S. David Kimball, David Floyd, J. Das et al. · Journal of Medicinal Chemistry · 1992 · 44 citations · Full text

Synthesis and biological evaluation of S-adenosyl-1,12-diamino-3-thio-9-azadodecane, a multisubstrate adduct inhibitor of spermine synthase

Patrick M. Woster, Alison Y. Black, Keith J. Duff et al. · Journal of Medicinal Chemistry · 1989 · 39 citations · Full text

Rows per page

1–5 of 9